Thyroid Diseases and Pregnancy

被引:0
|
作者
Karger, Stefan [1 ]
Fuehrer-Sakel, Dagmar [1 ]
机构
[1] Univ Klinikum Leipzig, Klin Endokrinol Diabetol & Nephrol, Dept Innere Med, D-04103 Leipzig, Germany
关键词
Hypothyroidism; Hyperthyroidism; Autoimmune thyroid disease; Thyroid nodules; Thyroid cancer; Pregnancy; TRANSIENT HYPERTHYROIDISM; HYPEREMESIS GRAVIDARUM; HYPOTHYROIDISM; WOMEN; DEFICIENCY; MANAGEMENT; MOTHERS; SUPPLEMENTATION; CONSEQUENCES; AGGRAVATION;
D O I
10.1007/s00063-009-1094-7
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Thyroid diseases in pregnancy must be recognized as a specific challenge for the clinician. Any pregnancy is causing alterations in thyroid hormone metabolism which have to be differentiated from pathologic states of thyroid function. Any thyroid disease of the mother with disturbances in the functional state of the gland could induce an adverse influence on the course of pregnancy. Furthermore, it can be associated with adverse consequences on fetal development. Especially hypothyroidism has to be avoided during pregnancy due to a danger of affected neurocognitive development of the offspring. Yet also maternal hyperthyroidism can lead to impairments in the course of pregnancy and to fetal thyroid dysfunction. Further clinical attention should be given to thyroid autoimmunity. There is a clear relationship between autoimmune thyroid disease and decreased fertility and an increase in the rate of spontaneous miscarriages. Furthermore, it displays an increased risk for the manifestation of postpartum thyroiditis. The management of nodular thyroid disease and malignancy does not differ from that of nonpregnant women/patients. Thyroid scintiscan and radioiodine therapy must be avoided during pregnancy and lactation. This review deals with the broad variety of thyroid disorders and function disturbances during and after pregnancy. All described diagnostic and therapeutic procedures are based upon the recent Clinical Practice Guideline of the Endocrine Society published in August 2007.
引用
收藏
页码:450 / 456
页数:7
相关论文
共 50 条
  • [21] Thyroid diseases before pregnancy in the pregnant state and postpartum
    Tkaczuk-Wlach, Joanna
    Sobstyl, Malgorzata
    Jakiel, Grzegorz
    MENOPAUSE REVIEW-PRZEGLAD MENOPAUZALNY, 2012, 11 (02): : 151 - 155
  • [22] Effects of Latent Toxoplasmosis on Autoimmune Thyroid Diseases in Pregnancy
    Kankova, Sarka
    Prochazkova, Lucie
    Flegr, Jaroslav
    Calda, Pavel
    Springer, Drahomira
    Potlukova, Eliska
    PLOS ONE, 2014, 9 (10):
  • [23] Thyroid diseases during pregnancy: A number of important issues
    Gerasimos Krassas
    Spyridon N. Karras
    Nikolaos Pontikides
    Hormones, 2015, 14 : 59 - 69
  • [25] Thyroid diseases during pregnancy: A number of important issues
    Krassas, Gerasimos
    Karras, Spyridon N.
    Pontikides, Nikolaos
    HORMONES-INTERNATIONAL JOURNAL OF ENDOCRINOLOGY AND METABOLISM, 2015, 14 (01): : 59 - 69
  • [26] Thyroid diseases in pregnancy other than Graves' disease and postpartum thyroid dysfunction
    Mestman, JH
    ENDOCRINOLOGIST, 1999, 9 (04): : 294 - 307
  • [27] The development of guidelines for management of thyroid diseases in pregnancy – current status
    Alicja Hubalewska-Dydejczyk
    Malgorzata Trofimiuk-Müldner
    Thyroid Research, 8 (Suppl 1)
  • [28] Thyroid Diseases and Adverse Pregnancy Outcomes in a Contemporary US Cohort
    Maennistoe, Tuija
    Mendola, Pauline
    Grewal, Jagteshwar
    Xie, Yunlong
    Chen, Zhen
    Laughon, S. Katherine
    JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2013, 98 (07): : 2725 - 2733
  • [29] THE IMPACT OF THYROID HORMONE DEFICIENCY DURING PREGNANCY IN INFECTIOUS DISEASES
    Nieto, P. A.
    Penaloza, H. F.
    Salazar-Echegarai, F. J.
    Castellanos, R. M.
    Opazo, M. C.
    Venegas, L.
    Kalergis, A. M.
    Riedel, C. A.
    Bueno, S. M.
    PLACENTA, 2017, 51 : 101 - 101
  • [30] Thyroid Diseases During Pregnancy: Bibliometric Analysis of Scientific Publications
    Yuan, Ning
    Wang, Li
    Li, Zhi
    Zhang, Xiaomei
    ENDOCRINE METABOLIC & IMMUNE DISORDERS-DRUG TARGETS, 2022, 22 (02) : 247 - 258